Stage IV Hilar Cholangiocarcinoma AJCC v8
3 clinical trials · Condition
◉ Watch Stage IV Hilar Cholangiocarcinoma AJCC v8
| Record | Firm | Date |
|---|---|---|
| NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma (NCT06420349) | Mayo Clinic | 2024-05-31 |
| Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial) (NCT05564403) | National Cancer Institute (NCI) | 2024-02-09 |
| Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma (NCT06178588) | University of Kansas Medical Center | 2024-02-01 |
Track Stage IV Hilar Cholangiocarcinoma AJCC v8 automatically
Every clearance here is in the API, with alerts when new ones post.